Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years — India, 2014 and updates on immunization

@article{Vashishtha2014IndianAO,
  title={Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years — India, 2014 and updates on immunization},
  author={Vipin M. Vashishtha and Panna Choudhury and A. N. Kalra and Anuradha Bose and Naveen Thacker and Vijay N. Yewale and C. P. Bansal and Pravin J Mehta},
  journal={Indian Pediatrics},
  year={2014},
  volume={51},
  pages={785-800}
}
JustificationThere is a need to review/revise recommendations about existing vaccines in light of recent developments in the field of vaccinology.ProcessFollowing an IAP ACVIP meeting on April 19 and 20, 2014, a draft of revised recommendations for the year 2014 and updates on certain vaccine formulations was prepared and circulated among the meeting participants to arrive at a consensus.ObjectivesTo review and revise recommendations for 2014 Immunization timetable for pediatricians in office… 

Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years — India, 2013 and updates on immunization

The committee has now recommended wP vaccines for the primary series of infant vaccination, and guidelines are now issued on the preference/selection of a particular aP vaccine in case it is not feasible to use wP vaccine, and use of Tdap vaccine during pregnancy.

Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP) Recommended Immunization Schedule (2018-19) and Update on Immunization for Children Aged 0 Through 18 Years

Four-dose schedule of anti-rabies vaccine for Post Exposure Prophylaxis as recommended by World Health Organization in 2018, is endorsed, and monoclonal rabies antibody can be administered as an alternative to Rabies immunoglobulin for post-exposure prophylactic.

Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP): Recommended Immunization Schedule (2020–21) and Update on Immunization for Children Aged 0 Through 18 Years

Recommendation of a booster dose of injectable polio vaccine at 4–6 years for children who have received the initial IPV doses as per the ACVIP/IAP schedule, re-emphasis on the importance of IPV in the primary immunization schedule, preferred timing of second dose of varicella vaccine at 3–6 months after the first dose, and uniform dosing recommendation.

Tdap during pregnancy

It would suggest that those who have received Tdap during adolescence do not need pertussis vaccine later because pertussi vaccine administered during adolescence provides long time protection and repeat dose of pertussIS vaccine may cause harm.

Improving vaccination coverage and timeliness through periodic intensification of routine immunization: evidence from Mission Indradhanush

The association between India's Mission Indradhanush (MI), a periodic intensification of the routine immunization program—which was implemented in phases across districts between March 2015 and July 2017, and routine vaccination coverage and timeliness among children is examined.

Human papillomavirus vaccination: Good clinical practice recommendations from the Federation of Obstetric and Gynecological Societies of India

Recommendations for HPV vaccination in India: Older women and women with abnormal screening results may be vaccinated with an understanding that vaccination does not protect against already acquired infections and screening has to continue, and increased awareness is required to reduce vaccine hesitancy.

A review of immunogenicity and tolerability of live attenuated Hepatitis A vaccine in children

The vaccine is found to be highly immunogenic with minimal or negligible safety issues, a single dose of live attenuated vaccine persists a long term immune response and can be a preferred option for developing countries.

IAP position paper on burden of mumps in India and vaccination strategies

A review of burden of mumps in India along with vaccination strategies to control the disease was prepared and revised final draft was later approved by IAP executive board in January 2015.

Pre-exposure rabies prophylaxis: a systematic review

The evidence available indicates that shorter regimens and regimens involving fewer doses are safe and immunogenic and that booster intervals could be extended up to 10 years, while the few studies on cost suggest that, at current vaccine and delivery costs, pre-exposure prophylaxis campaigns would not be cost-effective in most situations.
...

References

SHOWING 1-10 OF 35 REFERENCES

Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years — India, 2013 and updates on immunization

The committee has now recommended wP vaccines for the primary series of infant vaccination, and guidelines are now issued on the preference/selection of a particular aP vaccine in case it is not feasible to use wP vaccine, and use of Tdap vaccine during pregnancy.

Consensus recommendations on immunization and IAP immunization timetable 2012

The committee concludes that there are no safety concerns of Hib vaccines and there is a need of conducting more community based studies to gather more evidence on the superiority of one pneumococcal conjugate vaccine over other.

IAP perspectives on measles and rubella elimination strategies

The Academy’s Expert group on Immunization has discussed various issues pertaining to rubella vaccine introduction in to the Universal Immunization Program and recommends that the vaccine should be given early to have much higher coverage than introducing it late at the time of 1st booster of DPT.

Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age.

The MMR vaccine can be offered safely and with equal efficacy to children at 9 and 15 months of age, and the rise in the pre- and post-immunization geometrical mean titre was significant.

Impact of different dosing schedules on the immunogenicity of the human rotavirus vaccine in infants in Pakistan: a randomized trial.

In Pakistani infants, the immunogenicity of RV1 did not increase significantly with 3 doses at 6, 10, and 14 weeks compared to 2 doses at6 and 10 weeks, and additional strategies should be evaluated for improving rotavirus vaccine immunogensicity in high burden countries.

Pertussis vaccines: Position paper of Indian Academy of Pediatrics (IAP)

The Indian Academy of Pediatrics has now proposed whole-cell pertussis vaccines for the primary series of infant vaccination and recommended use of Tdap during each pregnancy to provide protection to the very young infants.

Safety and Immunogenicity of Early Vaccination with Two Doses of Tetravalent Measles-Mumps-Rubella-Varicella (MMRV) Vaccine in Healthy Children from 9 Months of Age

Early vaccination with two doses of this experimental MMRV vaccine at 9 and 12 months of age was well-tolerated and at least as immunogenic as two dosesof separate licensed MMR and varicella vaccines.

Measles, mumps and rubella immunization at nine months in a developing country

It is possible that a trivalent measles, mumps and rubella vacine can safely and effectively replace routine measles immunization at 9 months of age in this population of black children in South Africa.